NCT06445335View on ClinicalTrials.gov

Prevalence of NAFLD in T2DM Patients

NAActive, not recruitingINTERVENTIONAL

Enrollment

385

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

November 1, 2025

Study Completion Date

November 1, 2025

Conditions

NAFLDT2DType 2 DiabetesFatty Liver, Nonalcoholic

Interventions

DIAGNOSTIC_TEST

FibroScan

Performance of a FibroScan measurement.

Trial Locations (1)

3600

Ziekenhuis Oost-Limburg, Genk

All Listed Sponsors

lead

Ziekenhuis Oost-Limburg

OTHER